Results from the latest amyloid-busting dementia drug trial may spur efforts at earlier diagnosis.
Results from the latest amyloid-busting dementia drug trial may spur efforts at earlier diagnosis.
End of content
No more pages to load
From The Source
- Palliative Care Australia: Implementation will be key to success of Aged Care Act
- Amendment to the Australian Qualifications Framework Issuance Policy
- National Women’s Health Advisory Council communique – 22 November 2024
- AMA urges Healthscope, Bupa and AHSA to resolve funding disputes
- AHHA: Healthscope dropping insurers ‘a sign of things to come’
- National Notifiable Diseases Surveillance System (NNDSS) fortnightly reports – 14 October to 27 October 2024
- Collaboration and HTA reform are key to improving vaccination rates in Australia: Parliamentary Friends of Medicine Future of Vaccines event
- Have your say on Australia’s STI strategy
- Minister for Health and Aged Care, speech – 22 November 2024
- Bupa customers remain fully covered at Healthscope hospitals until February 2025
- AMA submission to Australian Drinking Water Guidelines Public Consultation on Draft Guidance for Per- and Polyfluoroalkyl Substances
- Alcidion secures contract with Peninsula Health for Miya Precision